Cavo M - Search Results

1

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.

Richardson PG, Kumar SK, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Gimsing P, Garderet L, Touzeau C, Buadi FK, Laubach JP, Cavo M, Darif M, Labotka R, Berg D, Moreau P. Richardson PG, et al. Among authors: cavo m. J Clin Oncol. 2021 Aug 1;39(22):2430-2442. doi: 10.1200/JCO.21.00972. Epub 2021 Jun 11. J Clin Oncol. 2021. PMID: 34111952 Clinical Trial.

2

Allogeneic bone marrow transplantation in multiple myeloma.

Tura S, Cavo M. Tura S, et al. Among authors: cavo m. Hematol Oncol Clin North Am. 1992 Apr;6(2):425-35. Hematol Oncol Clin North Am. 1992. PMID: 1582983 Review.

3

Prognostic variables and clinical staging in multiple myeloma.

Cavo M, Galieni P, Zuffa E, Baccarani M, Gobbi M, Tura S. Cavo M, et al. Blood. 1989 Oct;74(5):1774-80. Blood. 1989. PMID: 2790201 Free article.

4

M-2 protocol for melphalan-resistant and relapsing multiple myeloma.

Cavo M, Galieni P, Tassi C, Gobbi M, Tura S. Cavo M, et al. Eur J Haematol. 1988 Feb;40(2):168-73. doi: 10.1111/j.1600-0609.1988.tb00816.x. Eur J Haematol. 1988. PMID: 3345830

5

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

Gahrton G, Tura S, Ljungman P, Bladé J, Brandt L, Cavo M, Façon T, Gratwohl A, Hagenbeek A, Jacobs P, et al. Gahrton G, et al. Among authors: cavo m. J Clin Oncol. 1995 Jun;13(6):1312-22. doi: 10.1200/JCO.1995.13.6.1312. J Clin Oncol. 1995. PMID: 7751876 Free article.

6

Allogeneic bone marrow transplantation for the treatment of multiple myeloma. An overview of published reports.

Cavo M, Benni M, Cirio TM, Gozzetti A, Tura S. Cavo M, et al. Stem Cells. 1995 Aug;13 Suppl 2:126-31. doi: 10.1002/stem.5530130720. Stem Cells. 1995. PMID: 8520501 Review.

7

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.

Gahrton G, Svensson H, Björkstrand B, Apperley J, Carlson K, Cavo M, Ferrant A, Fouillard L, Gratecos N, Gratwohl A, Guilhot F, Lambertenghi Deliliers G, Ljungman P, Masszi T, Milligan DW, Powles RL, Reiffers J, Samson JD, Stoppa AM, Vernant JP, Volin L, Wallvik J. Gahrton G, et al. Among authors: cavo m. Bone Marrow Transplant. 1999 Oct;24(7):741-5. doi: 10.1038/sj.bmt.1701975. Bone Marrow Transplant. 1999. PMID: 10516677

8

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.

Martinelli G, Terragna C, Zamagni E, Ronconi S, Tosi P, Lemoli RM, Bandini G, Motta MR, Testoni N, Amabile M, Ottaviani E, Vianelli N, de Vivo A, Gozzetti A, Tura S, Cavo M. Martinelli G, et al. Among authors: cavo m. J Clin Oncol. 2000 Jun;18(11):2273-81. doi: 10.1200/JCO.2000.18.11.2273. J Clin Oncol. 2000. PMID: 10829048

9

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.

Tosi P, Zamagni E, Ronconi S, Benni M, Motta MR, Rizzi S, Tura S, Cavo M. Tosi P, et al. Among authors: cavo m. Leukemia. 2000 Jul;14(7):1310-3. doi: 10.1038/sj.leu.2401819. Leukemia. 2000. PMID: 10914557

10

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.

Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M. Tosi P, et al. Among authors: cavo m. Haematologica. 2002 Apr;87(4):408-14. Haematologica. 2002. PMID: 11940485 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

617 results

Search Page